Annual Total Long Term Liabilities
$522.60 M
-$27.10 M-4.93%
31 December 2023
Summary:
Emergent BioSolutions annual total long term liabilities is currently $522.60 million, with the most recent change of -$27.10 million (-4.93%) on 31 December 2023. During the last 3 years, it has fallen by -$529.10 million (-50.31%). EBS annual total long term liabilities is now -50.31% below its all-time high of $1.05 billion, reached on 31 December 2020.EBS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$739.50 M
+$232.00 M+45.71%
30 September 2024
Summary:
Emergent BioSolutions quarterly total long term liabilities is currently $739.50 million, with the most recent change of +$232.00 million (+45.71%) on 30 September 2024. Over the past year, it has increased by +$207.60 million (+39.03%). EBS quarterly long term liabilities is now -37.90% below its all-time high of $1.19 billion, reached on 30 September 2022.EBS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.9% | +39.0% |
| 3 y3 years | -50.3% | -24.5% |
| 5 y5 years | -48.7% | -27.8% |
EBS Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -50.3% | at low | -37.9% | +45.7% |
| 5 y | 5 years | -50.3% | at low | -37.9% | +45.7% |
| alltime | all time | -50.3% | +4876.2% | -37.9% | +6941.5% |
Emergent BioSolutions Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $739.50 M(+45.7%) |
| June 2024 | - | $507.50 M(-0.4%) |
| Mar 2024 | - | $509.50 M(-2.5%) |
| Dec 2023 | $522.60 M(-4.9%) | $522.60 M(-1.7%) |
| Sept 2023 | - | $531.90 M(+0.5%) |
| June 2023 | - | $529.30 M(-0.4%) |
| Mar 2023 | - | $531.50 M(-3.3%) |
| Dec 2022 | $549.70 M(-43.5%) | $549.70 M(-53.8%) |
| Sept 2022 | - | $1.19 B(+25.9%) |
| June 2022 | - | $945.50 M(-1.1%) |
| Mar 2022 | - | $955.90 M(-1.7%) |
| Dec 2021 | $972.20 M(-7.6%) | $972.20 M(-0.7%) |
| Sept 2021 | - | $979.40 M(-1.4%) |
| June 2021 | - | $993.70 M(-1.3%) |
| Mar 2021 | - | $1.01 B(-4.2%) |
| Dec 2020 | $1.05 B(+2.9%) | $1.05 B(-1.3%) |
| Sept 2020 | - | $1.07 B(+9.4%) |
| June 2020 | - | $973.60 M(-2.3%) |
| Mar 2020 | - | $996.80 M(-2.5%) |
| Dec 2019 | $1.02 B(+0.4%) | $1.02 B(-0.1%) |
| Sept 2019 | - | $1.02 B(-0.7%) |
| June 2019 | - | $1.03 B(+12.4%) |
| Mar 2019 | - | $917.80 M(-9.9%) |
| Dec 2018 | $1.02 B(+1661.4%) | $1.02 B(+870.0%) |
| Sept 2018 | - | $104.96 M(+1.2%) |
| June 2018 | - | $103.73 M(+3.4%) |
| Mar 2018 | - | $100.32 M(+73.6%) |
| Dec 2017 | $57.80 M(-78.4%) | $57.80 M(-79.7%) |
| Sept 2017 | - | $285.06 M(+2.9%) |
| June 2017 | - | $276.96 M(+1.3%) |
| Mar 2017 | - | $273.51 M(+2.0%) |
| Dec 2016 | $268.05 M(-3.5%) | $268.05 M(-2.2%) |
| Sept 2016 | - | $274.10 M(-2.1%) |
| June 2016 | - | $279.94 M(+0.5%) |
| Mar 2016 | - | $278.46 M(+0.2%) |
| Dec 2015 | $277.86 M | $277.86 M(-1.6%) |
| Sept 2015 | - | $282.51 M(-3.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | - | $294.11 M(-1.9%) |
| Mar 2015 | - | $299.67 M(+2.4%) |
| Dec 2014 | $292.55 M(+262.0%) | $292.55 M(+6.5%) |
| Sept 2014 | - | $274.74 M(+0.6%) |
| June 2014 | - | $273.06 M(-0.1%) |
| Mar 2014 | - | $273.43 M(+238.3%) |
| Dec 2013 | $80.81 M(+34.3%) | $80.81 M(+12.3%) |
| Sept 2013 | - | $71.97 M(+24.6%) |
| June 2013 | - | $57.75 M(-2.2%) |
| Mar 2013 | - | $59.04 M(-1.9%) |
| Dec 2012 | $60.20 M(+1.9%) | $60.20 M(-1.4%) |
| Sept 2012 | - | $61.04 M(+1.5%) |
| June 2012 | - | $60.15 M(+0.9%) |
| Mar 2012 | - | $59.60 M(+0.9%) |
| Dec 2011 | $59.08 M(+15.8%) | $59.08 M(-0.7%) |
| Sept 2011 | - | $59.53 M(+47.9%) |
| June 2011 | - | $40.25 M(-2.8%) |
| Mar 2011 | - | $41.42 M(-18.8%) |
| Dec 2010 | $51.04 M(+10.5%) | $51.04 M(+36.5%) |
| Sept 2010 | - | $37.38 M(-2.3%) |
| June 2010 | - | $38.26 M(-16.0%) |
| Mar 2010 | - | $45.55 M(-1.3%) |
| Dec 2009 | $46.17 M(+23.4%) | $46.17 M(+108.8%) |
| Sept 2009 | - | $22.11 M(-4.2%) |
| June 2009 | - | $23.07 M(-37.3%) |
| Mar 2009 | - | $36.80 M(-1.7%) |
| Dec 2008 | $37.42 M(-19.9%) | $37.42 M(-13.0%) |
| Sept 2008 | - | $43.00 M(-3.2%) |
| June 2008 | - | $44.43 M(-2.7%) |
| Mar 2008 | - | $45.66 M(-2.2%) |
| Dec 2007 | $46.69 M(+31.8%) | $46.69 M(-2.2%) |
| Sept 2007 | - | $47.75 M(+37.5%) |
| June 2007 | - | $34.72 M(-2.0%) |
| Mar 2007 | - | $35.41 M(-0.1%) |
| Dec 2006 | $35.44 M(+237.4%) | $35.44 M(-0.5%) |
| Sept 2006 | - | $35.61 M(+239.0%) |
| Dec 2005 | $10.50 M(-11.9%) | $10.50 M(-11.9%) |
| Dec 2004 | $11.92 M | $11.92 M |
FAQ
- What is Emergent BioSolutions annual total long term liabilities?
- What is the all time high annual total long term liabilities for Emergent BioSolutions?
- What is Emergent BioSolutions annual total long term liabilities year-on-year change?
- What is Emergent BioSolutions quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly long term liabilities year-on-year change?
What is Emergent BioSolutions annual total long term liabilities?
The current annual total long term liabilities of EBS is $522.60 M
What is the all time high annual total long term liabilities for Emergent BioSolutions?
Emergent BioSolutions all-time high annual total long term liabilities is $1.05 B
What is Emergent BioSolutions annual total long term liabilities year-on-year change?
Over the past year, EBS annual total long term liabilities has changed by -$27.10 M (-4.93%)
What is Emergent BioSolutions quarterly total long term liabilities?
The current quarterly long term liabilities of EBS is $739.50 M
What is the all time high quarterly long term liabilities for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly total long term liabilities is $1.19 B
What is Emergent BioSolutions quarterly long term liabilities year-on-year change?
Over the past year, EBS quarterly total long term liabilities has changed by +$207.60 M (+39.03%)